-
Loading metrics
Cost-effectiveness of pembrolizumab for advanced non-small cell lung cancer patients with varying comorbidity burden
- Steven D. Criss,
- Lauren Palazzo,
- Tina R. Watson,
- Adelle M. Paquette,
- Keith Sigel,
- Juan Wisnivesky,
- Chung Yin Kong
x
- Published: January 29, 2020
- https://doi.org/10.1371/journal.pone.0228288